Fundies. English
Segment disclosures
Company overviewOPKO Health, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
35 dimension combinations 495 retained observations 38 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Transfer Of Intellectual Property And Other · Diagnostics
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250501 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240507 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231106 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231106 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20240301 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20211028 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20211028 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10045000 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 16240000 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 20200506 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20200302 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20200302 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 0 | USD | 2019-05-08 · 03:36:25.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 0 | USD | 2019-03-02 · 02:03:00.000Z | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 20181109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 0 | USD | 20181109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 0 | USD | 20180807 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 0 | USD | 20180807 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 0 | USD | 2019-03-02 · 02:03:00.000Z | Open filing evidence |
Operating Segments · Transfer Of Intellectual Property And Other · Pharmaceutical
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 12266000 | USD | 20250501 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 77364000 | USD | 20250303 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 13218000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 34272000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 12306000 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 21054000 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 8749000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 180663000 | USD | 20250303 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6246000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 165938000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 94866000 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 159692000 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 64826000 | USD | 20240507 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 105721000 | USD | 20250303 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 4500000 | USD | 20231106 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 97659000 | USD | 20231106 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 87197000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 93159000 | USD | 20230803 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 25842000 | USD | 20240301 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4269000 | USD | 20210428 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 9553000 | USD | 20210428 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 73317000 | USD | 20200302 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 21472000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 58961000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 19230000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 37490000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 18259000 | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 69906000 | USD | 20200302 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 21609000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 56463000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 19107000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 34855000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 15748000 | USD | 2019-05-08 · 03:36:25.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 75537000 | USD | 20200302 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 22369000 | USD | 20181109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 67697000 | USD | 20181109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 29723000 | USD | 20180807 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 45328000 | USD | 20180807 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 105455000 | USD | 2019-03-02 · 02:03:00.000Z | Open filing evidence |
Operating Segments · Product · Diagnostics
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250501 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240507 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231106 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231106 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20240301 | Open filing evidence |
Operating Segments · Product · Pharmaceutical
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 34842000 | USD | 20250501 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 155111000 | USD | 20250303 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 39143000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 117675000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 40485000 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 78532000 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 38047000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 167557000 | USD | 20250303 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 40670000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 124553000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 43500000 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 83883000 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 40383000 | USD | 20240507 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 142845000 | USD | 20250303 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 32388000 | USD | 20231106 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 104938000 | USD | 20231106 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 35892000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 72550000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 36658000 | USD | 20230503 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 141770000 | USD | 20240301 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 33945000 | USD | 20210428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 119952000 | USD | 20220301 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 31074000 | USD | 20210428 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 112184000 | USD | 20220301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 26161000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 80143000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 28680000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 53981000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 25301000 | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 107112000 | USD | 20200302 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 25395000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 81769000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 28523000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 56374000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 27851000 | USD | 2019-05-08 · 03:36:25.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 107759000 | USD | 20200302 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 22795000 | USD | 20181109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 73992000 | USD | 20181109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 28966000 | USD | 20180807 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 51197000 | USD | 20180807 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 83467000 | USD | 2019-03-02 · 02:03:00.000Z | Open filing evidence |
Operating Segments · Service · Diagnostics
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 102844000 | USD | 20250501 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 480667000 | USD | 20250303 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 121271000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 377557000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 129395000 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 256286000 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 126890000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 515275000 | USD | 20250303 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 131679000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 391100000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 127052000 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 259420000 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 132368000 | USD | 20240507 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 755630000 | USD | 20250303 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 142856000 | USD | 20231106 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 616259000 | USD | 20231106 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 186804000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 473402000 | USD | 20230803 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1607106000 | USD | 20240301 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 170839000 | USD | 20200506 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 716434000 | USD | 20200302 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 181139000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 538488000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 178458000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 357349000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 178891000 | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 813248000 | USD | 20200302 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 202811000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 630180000 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 216055000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 427369000 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 211315000 | USD | 2019-05-08 · 03:36:25.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 782710000 | USD | 20200302 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 200876000 | USD | 20181109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 663333000 | USD | 20181109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 233912000 | USD | 20180807 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 462456000 | USD | 20180807 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 928572000 | USD | 2019-03-02 · 02:03:00.000Z | Open filing evidence |
Operating Segments · Service · Pharmaceutical
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250501 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240807 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240507 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250303 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231106 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231106 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230503 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20240301 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20210428 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 20210428 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20200302 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20200302 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 0 | USD | 2019-11-06 · 02:25:25.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 2019-08-08 · 00:29:15.000Z | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 0 | USD | 2019-05-08 · 03:36:25.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 0 | USD | 20200302 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 0 | USD | 20181109 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 0 | USD | 20181109 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 0 | USD | 20180807 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 0 | USD | 20180807 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 0 | USD | 2019-03-02 · 02:03:00.000Z | Open filing evidence |
Operating Segments · Diagnostics · Transfer Of Intellectual Property And Other
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260828 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20221108 | Open filing evidence |
Operating Segments · Diagnostics · Product
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260828 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230503 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230503 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 0 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 20211028 | Open filing evidence |
Operating Segments · Diagnostics · Service
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 74549000 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 146735000 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 72186000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 370275000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 95244000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 299190000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 101101000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 203945000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 102844000 | USD | 20260828 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 480667000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 121271000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 377557000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 129395000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 256286000 | USD | 20250731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 515275000 | USD | 20260226 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 132368000 | USD | 20230503 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 142856000 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 616259000 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 286599000 | USD | 20230503 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 340163000 | USD | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1244312000 | USD | 20221108 | Open filing evidence |
Operating Segments · Pharmaceutical · Transfer Of Intellectual Property And Other
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 8768000 | USD | 20211028 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 22585000 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 36979000 | USD | 20210218 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 6819000 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 31057000 | USD | 20211028 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 72521000 | USD | 20210218 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 69906000 | USD | 20210218 | Open filing evidence |
Operating Segments · Pharmaceutical · Product
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 142845000 | USD | 20230227 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 141770000 | USD | 20230227 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 36882000 | USD | 20211028 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 106490000 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 119952000 | USD | 20230227 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 28702000 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 89133000 | USD | 20211028 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 112184000 | USD | 20210218 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 107112000 | USD | 20210218 | Open filing evidence |
Operating Segments · Pharmaceutical · Service
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230227 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230227 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 0 | USD | 20230227 | Open filing evidence |
Transfer Of Intellectual Property And Other · Operating Segments · Diagnostics
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230503 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230503 | Open filing evidence |
Transfer Of Intellectual Property And Other · Operating Segments · Pharmaceutical
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 64826000 | USD | 20230503 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 105721000 | USD | 20230227 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 87197000 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 93159000 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 5962000 | USD | 20230503 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 25842000 | USD | 20230227 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 9548000 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 13816000 | USD | 20220804 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 36979000 | USD | 20230227 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 14686000 | USD | 20210729 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 24239000 | USD | 20210729 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 72521000 | USD | 20220301 | Open filing evidence |
Transfer Of Intellectual Property And Other · Diagnostics · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 0 | USD | 20220509 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20220301 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 16240000 | USD | 20220301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10045000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 16240000 | USD | 20201029 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20220301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201029 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20201029 | Open filing evidence |
Transfer Of Intellectual Property And Other · Pharmaceutical · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 5962000 | USD | 20220509 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4269000 | USD | 20220509 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 6819000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 31057000 | USD | 20201029 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 20676000 | USD | 20201029 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 58165000 | USD | 20201029 | Open filing evidence |
Product · Operating Segments · Pharmaceutical
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 35892000 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 72550000 | USD | 20220804 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 35663000 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 69608000 | USD | 20220804 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 29356000 | USD | 20210729 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 60430000 | USD | 20210729 | Open filing evidence |
Product · Diagnostics · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20220509 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20220509 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 0 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 20201029 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201029 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20201029 | Open filing evidence |
Product · Pharmaceutical · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 36658000 | USD | 20220509 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 33945000 | USD | 20220509 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 28702000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 89133000 | USD | 20201029 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 26161000 | USD | 20201029 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 80143000 | USD | 20201029 | Open filing evidence |
Service · Operating Segments · Diagnostics
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2021-09-30 | 340163000 | USD | 20211028 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1244312000 | USD | 20211028 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 382498000 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 804309000 | USD | 20211028 | Open filing evidence |
Service · Operating Segments · Pharmaceutical
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20220301 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20211028 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20211028 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 0 | USD | 20220301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 0 | USD | 20211028 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 20211028 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20210729 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 20210729 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20220301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20210218 | Open filing evidence |
Service · Diagnostics · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-12-31 | 1607106000 | USD | 20220301 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1262242000 | USD | 20220301 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 716434000 | USD | 20220301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 813248000 | USD | 20210218 | Open filing evidence |
Service · Pharmaceutical · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 20200731 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 20200731 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 20200731 | Open filing evidence |
Diagnostics · Operating Segments · Transfer Of Intellectual Property And Other
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 0 | USD | 20210428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 16240000 | USD | 20210218 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 20210428 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20210218 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20210218 | Open filing evidence |
Diagnostics · Operating Segments · Product
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230227 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230227 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20210428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 0 | USD | 20230227 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 20210428 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20220301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20210218 | Open filing evidence |
Diagnostics · Operating Segments · Service
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 755630000 | USD | 20230227 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1607106000 | USD | 20230227 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 506951000 | USD | 20210428 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1262242000 | USD | 20230227 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 382498000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 804309000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 170839000 | USD | 20210428 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 181139000 | USD | 20201029 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 538488000 | USD | 20201029 | Open filing evidence |
Diagnostics · Transfer Of Intellectual Property And Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230227 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230227 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 0 | USD | 20220804 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 16240000 | USD | 20230227 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 6194000 | USD | 20210729 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 6194000 | USD | 20210729 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 20200731 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 20200731 | Open filing evidence |
Diagnostics · Product · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-04-01 – 2021-06-30 | 0 | USD | 20210729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 0 | USD | 20210729 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20210729 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 20210729 | Open filing evidence |
Diagnostics · Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:DiagnosticsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 186804000 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 473402000 | USD | 20220804 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 286599000 | USD | 20220509 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 397197000 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 904149000 | USD | 20220804 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 506951000 | USD | 20220509 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 250971000 | USD | 20210729 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 421811000 | USD | 20210729 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 178458000 | USD | 20200731 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 357349000 | USD | 20200731 | Open filing evidence |
Pharmaceutical · Operating Segments · Transfer Of Intellectual Property And Other
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 46090000 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 60058000 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 13968000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 79680000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 18749000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 45978000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 14963000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 27229000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 12266000 | USD | 20260828 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 77364000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 13218000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 34272000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 12306000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 21054000 | USD | 20250731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 180663000 | USD | 20260226 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 4500000 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 97659000 | USD | 20221108 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8768000 | USD | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 22585000 | USD | 20221108 | Open filing evidence |
Pharmaceutical · Operating Segments · Product
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 42941000 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 80984000 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 38042000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 156924000 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 37676000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 113261000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 40743000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 75585000 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 34842000 | USD | 20260828 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 155111000 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 39143000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 117675000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 40485000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 78532000 | USD | 20250731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 167557000 | USD | 20260226 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 32388000 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 104938000 | USD | 20221108 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 36882000 | USD | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 106490000 | USD | 20221108 | Open filing evidence |
Pharmaceutical · Operating Segments · Service
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260828 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260828 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250731 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260226 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20221108 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 0 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 20201029 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201029 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20201029 | Open filing evidence |
Pharmaceutical · Transfer Of Intellectual Property And Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ProductOrServiceAxis=opk:TransferOfIntellectualPropertyAndOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 14686000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 24239000 | USD | 20200731 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 19230000 | USD | 20200731 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 37490000 | USD | 20200731 | Open filing evidence |
Pharmaceutical · Product · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 29356000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 60430000 | USD | 20200731 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 28680000 | USD | 20200731 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 53981000 | USD | 20200731 | Open filing evidence |
Pharmaceutical · Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=opk:PharmaceuticalMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 0 | USD | 20220509 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20220509 | Open filing evidence |